Potential new sleep biomarker for neurodegenerative diseases


  • A combination of phasic and tonic electromyographic (EMG) activity is the strongest indicator of developing neurodegenerative diseases in the future.

Why this matters ?

  • Idiopathic rapid eye movement (REM) sleep behavior disorder (iRBD) is associated with the development of neurodegenerative diseases such as Parkinson’s disease, however, there is no defined biomarker for iRBD.

  • Biomarkers for iRBD may help predict, prevent, and slow the development of neurodegenerative diseases.